thcfreecbd.shop

Latin America & Caribbean Laws by Country — THC‑Free CBD 2025

This page provides a cautious, high‑level orientation to how selected countries in Latin America and the Caribbean treat CBD products marketed as “THC‑free.” It is not legal advice. Policies change and enforcement varies. Verify with competent national authorities (health/medicines regulators, standards bodies, customs) and current statutes/regulations. Reviewed through early 2025.

On this page

What “THC‑free” means here

“THC‑free” is a laboratory reporting outcome (e.g., THC reported as Not Detected at the lab’s Limit of Quantitation on a batch Certificate of Analysis). It is not, by itself, a legal category. Even with ND‑THC COAs, many jurisdictions require product registrations, specific categories (e.g., medicines, cosmetics), and compliant labels. Always confirm the legal pathway for the product type (ingestible, topical, vape, pet) in the country concerned.

How to use this page

Use these brief notes as orientation only. Then:

Country‑by‑country quick notes

Notes emphasize product categories, import/retail realities, and where to verify. Wording is conservative; enforcement can differ by port, province/state, and agency.

Mexico

  • At a glance: CBD has been discussed within health product frameworks. Consumer retail of ingestible CBD has seen mixed practice and evolving guidance. Treat ingestibles as higher‑risk without clear, current authorization. Cosmetics with CBD may follow different rules.
  • Regulators to check: COFEPRIS (Federal Commission for the Protection against Sanitary Risk); customs authorities.
  • Import & retail: Personal imports and commercial distribution can require prior permits/registration. Verify label language (Spanish), claims, and documentation.

Brazil

  • At a glance: CBD products are commonly routed through medical pathways under ANVISA oversight. Non‑prescription retail of ingestibles is constrained.
  • Regulators to check: ANVISA; Receita Federal (customs).
  • Import & retail: Patient‑specific authorizations and prescription contexts are typical for CBD access. Cosmetics have separate rules.

Colombia

  • At a glance: Established cannabis/hemp framework mainly geared to licensed production. Consumer CBD retail varies by format and registration status; ingestibles often face stricter paths than cosmetics/topicals.
  • Regulators to check: Ministry of Health/INVIMA; Ministry of Justice (licensing); DIAN (customs).
  • Import & retail: Expect documentation on origin, THC content (ND/LOQ), and product category. Claims tightly controlled.

Argentina

  • At a glance: Medical‑oriented access for cannabinoids; consumer OTC ingestibles are sensitive. Cosmetics and topicals may follow different provisions.
  • Regulators to check: ANMAT; customs.
  • Import & retail: Check for prescription/registration requirements and labeling/Spanish language standards.

Chile

  • At a glance: Cannabinoid products intersect with health product rules. Retail availability of ingestible CBD remains constrained; topicals/cosmetics may be more feasible subject to registrations.
  • Regulators to check: ISP (Public Health Institute); National Customs Service.

Peru

  • At a glance: Medical cannabis framework in place; CBD often handled via pharmacy/medical channels. Consumer ingestibles without medical routing are sensitive.
  • Regulators to check: DIGEMID; SUNAT (customs).

Uruguay

  • At a glance: Pioneering cannabis reforms, but CBD product types still follow defined channels. Do not assume free consumer import/retail for ingestibles without registration.
  • Regulators to check: MSP (Ministry of Public Health); IRCCA (cannabis institute); customs.

Paraguay

  • At a glance: Medical cannabis regulations exist; non‑medical CBD retail/import of ingestibles is sensitive. Documentation and product category clarity are essential.
  • Regulators to check: Ministry of Public Health; customs.

Costa Rica

  • At a glance: Reforms have addressed hemp and cannabis categories; implementation details for consumer CBD vary by product type. Cosmetics/topicals may be more straightforward than ingestibles.
  • Regulators to check: Ministry of Health; customs.

Panama

  • At a glance: Medical framework emerging; commercial consumer CBD (especially ingestibles) should be treated cautiously pending clear, published retail rules.
  • Regulators to check: Ministry of Health; customs.

Dominican Republic

  • At a glance: Cannabinoid controls are strict; do not assume CBD ingestibles are permitted for travelers or mailings. Topicals/cosmetics also require scrutiny.
  • Regulators to check: Ministry of Public Health; customs.

Jamaica

  • At a glance: Cannabis authority oversees licensing; retail CBD depends on category and compliance. Tourism settings do not equal blanket legality.
  • Regulators to check: Cannabis Licensing Authority; Ministry of Health & Wellness; customs.

Trinidad & Tobago

  • At a glance: Controlled‑substances framework is strict. Treat CBD ingestibles and imports as high risk absent explicit, current permission.
  • Regulators to check: Ministry of Health; customs.

Other Caribbean jurisdictions (overview)

  • At a glance: Many islands maintain conservative controlled‑substance laws. “THC‑free” on a COA does not create a travel or mail pathway. Verify directly with government sources before carrying or shipping any CBD product.
  • Who to check: Health/medicines regulators, customs/port authorities, and any national cannabis/hemp authority.

How to verify quickly

  • Identify the competent authority (e.g., Ministry of Health/Medicines Agency, standards bureau, customs service).
  • Search official sites (in the local language) for “cannabidiol,” “cannabis,” “hemp,” “cosmetic,” “supplement,” and “import permit.”
  • Confirm if your product type (ingestible vs cosmetic/topical vs vape) is addressed and whether authorizations/registrations are required.
  • When in doubt, contact the authority in writing; retain replies. For shipping, consider a customs broker.

Travel and cross‑border movement

  • Carrying CBD across borders: Elevated risk. Many jurisdictions do not permit personal import of ingestibles without prescriptions/permits—even if “THC‑free.” See International Travel Guidelines.
  • Mailing goods: Cross‑border shipments face seizure/return if not compliant with destination rules. See Mailing THC‑Free CBD Internationally & Customs.
  • Documentation: Keep original packaging and a recent, batch‑matched COA showing ND‑THC with LOQ stated. This does not substitute for permits.

FAQ

Is “THC‑free” CBD broadly legal across LAC?
No. “THC‑free” is a lab result, not a legal category. Many countries require medical pathways, registrations, or prohibit consumer ingestibles.

Are cosmetics/topicals easier to place on the market?
Often they follow different rules than ingestibles, but registration, labeling, and claims controls still apply.

Can I mail “THC‑free” CBD to friends in the Caribbean?
Treat as high risk. Verify destination import rules and carrier policies, or use a customs broker. See our international mailing guide.

Will an ND‑THC COA guarantee entry at the border?
No. Border decisions rely on local law and declared category/permits, not just a COA.

Where should I start verification?
Health/medicines regulators and customs websites. Search in the local language for the exact product type.

Disclaimer: This page is for general information and is not legal advice. Always verify with official sources before buying, selling, mailing, or carrying CBD products.